A-Z Index
Image Cart
              

 Information For:

Manufacturers

Regulator

Healthcare

Consumers

Members




What is Pharmacopeial Forum?

Pharmacopeial Forum (PF) is the journal through which USP develops and revises USP–NF standards by a process of public review and comment. All changes and additions to the USP–NF are first proposed in the PF to invite public comment. PF provides guidance on how to submit comments and input. A summary of the comments received and USP's responses are also featured in the PF. PF is published once every two months, in print and online. New issues of PF are available in January, March, May, July, September, and November each year.

PF Highlights and Stimuli Articles

See which issues of Pharmacopeial Forum feature information of specific interest to you—choose from the options below to view the lists of content of any issues.

Current issue: November–December 2009

PF Highlights Stimuli Articles

Vol. 35, No. 6,  (549KB)
(November-December 2009)


Errata  (38KB)

Pharmacopeial Standards for the Subdivision Characteristics of Scored Tablets  (134KB)

A Recombinant Factor C Procedure for the Detection of Gram-negative Bacterial Endotoxin  (1.7MB)

Transfer of HPLC Procedures to Suitable Columns of Reduced Dimensions and Particle Sizes  (931KB)



Past issues: 2009

PF Highlights Stimuli Articles

Vol. 35, No. 5,  (629KB)
September–October 2009

Interim Revision Announcements  (103KB) Pertaining to USP 32–NF 27 (Official October 1, 2009)


Errata  (41KB)

General Chapter Management in the 2010–2015 Cycle  (200KB)

Transfer of Analytical Procedures: A Proposal for a New General Information Chapter  (56KB)

Visible Particulates in Injections—A History and a Proposal to Revise USP General Chapter Injections <1>  (82KB)

Vol. 35, No. 4,  (327KB)
July–August 2009

Interim Revision Announcements  (85KB) Pertaining to USP 32–NF 27 (Official August 1, 2009)

  • Hawthorn Leaf with Flower
  • Powdered Hawthorn Leaf with Flower

Errata  (61KB)

Co-processed Excipients  (62KB)

Liquid-filled Gelatin Capsules  (2.7MB)

Vol. 35, No. 3,  (867KB)
May-June 2009

Interim Revision Announcements  (77KB) Pertaining to USP32–NF 27 (Official June 1, 2009)

  • Amantadine Hydrochloride Capsules
  • Bupropion Hydrochloride Extended–Release Tablets

Errata  (44KB)

Drug Product Performance and Interchangeability of Multisource Drug Substances and Drug Products  (2.4MB)

Topical and Transdermal Drug Products  (2.4MB)

Performance–based Monographs  (2.4MB)

Acceptable, Equivalent, or Better: Approaches for Alternatives to Official Compendial Procedures  (2.4MB)

Vol. 35, No. 2,  (506KB)
March - April 2009

Interim Revision Announcements Pertaining to USP 31–NF 26(official March 1, 2009)
  • Galantamine Tablets  (104KB)
  • USP Redesigns Pharmacopeial Forum
  • USP Implements Guideline on Use of Accelerated Revision Processes
  • USP Issues Call for Candidates for 2010-2015 Council of Experts, Its Expert Committees, and Its Advisory Panels

Errata  (63KB)

A Discussion of Net Water Gain for Water Vapor Transmission Rate Determinations  (535KB)

Vol. 35, No. 1,  (750KB)
January–February 2009

Interim Revision Announcements Pertaining to USP 31–NF 26(official February 1, 2009)

  • <1052> Biotechnology-Derived Articles – Amino Acids Analysis
  • <1053> Biotechnology-Derived Articles – Capillary Electrophoresis
  • <1054> Biotechnology-Derived Articles – Isoelectric Focusing
  • <1055> Biotechnology-Derived Articles – Peptide Mapping
  • <1056> Biotechnology-Derived Articles – Polyacrylamide Gel Electrophoresis
Proposed Revisions to Monographs
  • Amantadine Hydrochloride Capsules
  • Bupropion Hydrochloride Extended-Release Tablets

There are no stimuli articles at this time.


Past issues: 2008

PF Highlights Stimuli Articles
Vol. 34, No. 6,  (2.5MB)
November–December 2008

USP Responses to Comments on Stimuli Article: The Application of Uncertainty to USP's Compendial Reference Standards Program: Certified Reference Materials  (527KB)

The Use of Inductively Coupled Plasma–Optical Emission Spectroscopy in the Determination of Heavy Metals in Crospovidone and Povidone as a Replacement for the Concomitant Visual Comparison Test  (527KB)

Compendial Calculations: Recommendations for Improving USP–NF Calculations  (527KB)

General Chapter Containers–Packaging Auxiliary Components <670>  (527KB)

Description of the Upcoming Change in Data Analysis for USP Dissolution Performance Verification Tests  (527KB)

USP Responses to Comments on Stimuli Article Uncertainty Statements Regarding USP Reference Standards  (527KB)

Redesign of the United States Pharmacopeia and National Formulary  (527KB)

Vol. 34, No. 5,  (1.7MB)
September–October 2008

General Chapter on Inorganic Impurities: Heavy Metals  (336KB)

The Cadaver Skin Absorption Model and the Drug Development Process  (331KB)

Vol. 34, No. 4,  (1.3MB)
July–August 2008

The Inhalation Ad Hoc Advisory Panel for the USP Performance Tests of Inhalation Dosage Forms  (625KB)

Use of Scanning Electron Microscopy in the Authentication of Botanicals  (152KB)

Vol. 34, No. 3,  (556KB)
May—June 2008

Making Sense of Trueness, Precision, Accuracy, and Uncertainty  (844KB)

Product Performance Test for Medicated Chewing Gums  (1.6MB)

Vol. 34, No. 2,  (621KB)
March—April 2008

Proposed Change to Acceptance Criteria for Dissolution Performance Verification Testing  (78KB)

Uncertainty Statements Regarding USP Reference Standards  (655KB)

Revision of USP General Chapter Elastomeric Closures for Injection <381>  (215KB)

Vol. 34, No. 1,  (943KB)
January—February 2008
 

Past issues: 2007

PF Highlights Stimuli Articles
Vol. 33, No. 6,  (883KB)
November—December 2007

Proposed New USP General Information Chapter, Excipient Performance <1059>  (146KB)

The Application of Uncertainty to USP's Compendial Reference Standards Program: Certified Reference Materials  (1.6MB)

Vol. 33, No. 5,  (570KB)
September—October 2007

Toward a Uniform System for Naming Vaccines and Polyclonal Immune Globulins  (123KB)

Vol. 33, No. 4,  (587KB)
July—August 2007

Assessing Antioxidant Activity in Botanicals and Other Dietary Supplements  (795KB)

Vol. 33, No. 3,  (606KB)
May—June 2007

Proposed Change to Acceptance Criteria for Dissolution Performance Verification Testing  (1MB)

Summary of Planned Revisions to Design and Analysis of Biological Assays <111>  (70KB)

Vol. 33, No. 2,  (294KB)
March—April 2007

A New Validated Differential Scanning Calorimetric Procedure for Monitoring the Less Active R,S Isomer of Ethambutol Dihydrochloride in Bulk Drug Samples and Anti-tuberculosis Formulations  (310KB)

Vol. 33, No. 1,  (339KB)
January—February 2007
 

Past issues: 2006

PF Highlights
Vol. 32, No. 6,  (897KB)
November—December 2006
Vol. 32, No. 5,  (1.2MB)
September—October 2006
Vol. 32, No. 4,  (1.1MB)
July—August 2006
Vol. 32, No. 3,  (682KB)
May—June 2006
Vol. 32, No. 2,  (313KB)
March—April 2006
Vol. 32, No. 1,  (442KB)
January—February 2006

What's New

PF 35(6) Errata (10/30/09)

New official Text for October: 15 Revisions Bulletins (10/30/09)

PF 35(6), November-December 2009: Highlights and Stimuli Articles (10/23/09)

Admission Criteria and Safety Classification for Dietary Supplements Guideline (10/22/09)

Elemental Impurities Hot Topics information updated (10/13/09)

General Chapter <1151> Pharmaceutical Dosage Forms (10/06/09)

Heparin Hot Topics information updated (10/02/09)

New Official Text for September (09/29/09)

Pending Standards for the month of September (09/25/09)

PF 35(5) IRAs and Errata (08/31/09)

PF Redesign

Related Resources